Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Prepaid Assets (2016 - 2026)

Syndax Pharmaceuticals (SNDX) has disclosed Prepaid Assets for 12 consecutive years, with $54000.0 as the latest value for Q1 2026.

  • For Q1 2026, Prepaid Assets rose 54.29% year-over-year to $54000.0; the TTM value through Mar 2026 reached $54000.0, up 54.29%, while the annual FY2025 figure was $1.2 million, 85.73% down from the prior year.
  • Prepaid Assets hit $54000.0 in Q1 2026 for Syndax Pharmaceuticals, down from $1.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $9.9 million in Q2 2025 and bottomed at $35000.0 in Q1 2025.
  • Average Prepaid Assets over 5 years is $2.4 million, with a median of $1.6 million recorded in 2024.
  • Year-over-year, Prepaid Assets soared 13457.14% in 2024 and then plummeted 99.42% in 2025.
  • Syndax Pharmaceuticals' Prepaid Assets stood at $1.9 million in 2022, then tumbled by 96.71% to $63000.0 in 2023, then skyrocketed by 13457.14% to $8.5 million in 2024, then plummeted by 85.73% to $1.2 million in 2025, then tumbled by 95.57% to $54000.0 in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $54000.0, $1.2 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.